Identification of MTCP1 as a significant factor in the pathogenesis of CLL provides an additional molecular target for consideration in this disease, and an archetypical process for the future pursuit of rare balanced translocations for the identification of genes relevant to pathogenesis and progression in many cancers. The gene discussed is MTCP1; the disease is B-cell chronic lymphocytic leukemia.